{"name":"Janssen-Cilag, S.A.","slug":"janssen-cilag-sa","ticker":"","exchange":"","domain":"janssencilagsa.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"Rabeprazol","genericName":"Rabeprazol","slug":"rabeprazol","indication":"Duodenal Ulcer due to H. Pylori","status":"discontinued"},{"name":"Vagitrol V","genericName":"Vagitrol V","slug":"vagitrol-v","indication":"Gastroesophageal reflux disease (GERD)","status":"phase_3"},{"name":"antipsychotic medications","genericName":"antipsychotic medications","slug":"antipsychotic-medications","indication":"Other","status":"phase_2"},{"name":"antipsychotics","genericName":"antipsychotics","slug":"antipsychotics","indication":"Other","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Fentanyl-TTS","genericName":"Fentanyl-TTS","slug":"fentanyl-tts","indication":"Chronic pain in opioid-tolerant patients","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Gynoclin V","genericName":"Gynoclin V","slug":"gynoclin-v","indication":"Bacterial vaginosis","status":"phase_3"}]}],"pipeline":[{"name":"Fentanyl-TTS","genericName":"Fentanyl-TTS","slug":"fentanyl-tts","phase":"marketed","mechanism":"Fentanyl-TTS is a transdermal patch that delivers the opioid fentanyl through the skin at a controlled rate to provide long-acting pain relief.","indications":["Chronic pain in opioid-tolerant patients","Cancer pain","Severe chronic pain requiring opioid therapy"],"catalyst":""},{"name":"Rabeprazol","genericName":"Rabeprazol","slug":"rabeprazol","phase":"discontinued","mechanism":"Sterile alpha and TIR motif-containing protein 1, ATP-binding cassette sub-family G member 2, Adenosine receptor A3","indications":["Duodenal Ulcer due to H. Pylori","Duodenal ulcer disease","Gastroesophageal reflux disease","Maintenance of Healing Gastroesophageal Reflux","Multiple endocrine adenomas"],"catalyst":""},{"name":"Gynoclin V","genericName":"Gynoclin V","slug":"gynoclin-v","phase":"phase_3","mechanism":"Gynoclin V is a clindamycin-based vaginal formulation that inhibits bacterial protein synthesis to treat vaginal infections.","indications":["Bacterial vaginosis","Vaginal infections caused by susceptible bacteria"],"catalyst":""},{"name":"Vagitrol V","genericName":"Vagitrol V","slug":"vagitrol-v","phase":"phase_3","mechanism":"Vagitrol V is a medication that works by inhibiting the action of a specific enzyme.","indications":["Gastroesophageal reflux disease (GERD)","Erosive esophagitis"],"catalyst":""},{"name":"antipsychotic medications","genericName":"antipsychotic medications","slug":"antipsychotic-medications","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"antipsychotics","genericName":"antipsychotics","slug":"antipsychotics","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":6,"phaseCounts":{"marketed":2,"discontinued":1,"phase_3":2,"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}